Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
These initiatives reflect Wisp's commitment to providing affordable, inclusive healthcare for women, complementing WELL's strategic vision of expanding access to high-quality care
A Certificate of Analysis is included with every order
The product was removed from refrigerated storage for an extended period of time.Recall Initiation Date: April 9, 2025Link: FDA Enforcement Report Facility Inspections FDA Warning Letters ProRx, LLC Type: Compounding pharmacy and FDA-registered outsourcing facilityFDA Department issuing Warning: Center for Drug Evaluation and Research (CDER)Warning Letter Date: January 15, 2025Facility Location: Exton, PennsylvaniaInspection Dates: July 15, 2024, to August 2, 2024
At 24 months, there was a 68% reduction in papilledema risk
A reduction in CRP has been linked to a lower risk of heart disease, stroke, and metabolic disorders such as insulin resistance and type 2 diabetes
